Satisfactory outcome after intensive chemotherapy with pragmatic use of minimal residual disease (MRD) monitoring in older patients with Philadelphia-negative B cell precursor acute lymphoblastic leukaemia: a Swedish registry-based study

2015 ◽  
Vol 32 (4) ◽  
Author(s):  
Emma Bergfelt ◽  
Piotr Kozlowski ◽  
Lucia Ahlberg ◽  
Erik Hulegårdh ◽  
Hans Hägglund ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukaemia ◽  
B Cell ◽  
Minimal Residual Disease ◽  
Lymphoblastic Leukaemia ◽  
Older Patients ◽  
Residual Disease ◽  
Intensive Chemotherapy ◽  
Cell Precursor ◽  
Satisfactory Outcome ◽  
Minimal Residual

scholarly journals Regenerating normal B-cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual disease

2000 ◽  
Vol 110 (1) ◽  
pp. 139-146 ◽  
Author(s):  
Elisabeth R. Van Wering ◽  
Birgit E. M. Van der Linden-Schrever ◽  
Tomasz Szczepański ◽  
Marja J. Willemse ◽  
Ed A. Baars ◽  
...  
Keyword(s):  
Acute Lymphoblastic Leukaemia ◽  
B Cell ◽  
Minimal Residual Disease ◽  
Lymphoblastic Leukaemia ◽  
Residual Disease ◽  
B Cell Precursors ◽  
Minimal Residual
Sign in / Sign up

Export Citation Format

Share Document